Advertisement
Screener

HERON THERAPEUTICS, INC. /DE/ (HRTX) Form D

HERON THERAPEUTICS, INC. /DE/ Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2023-08-01: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; Date of first sale 2023-07-25; Total offering amount $30,000,000.
  • 2011-07-11: Federal exemption Rule 506; Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2011-07-01; Total offering amount $24,000,001.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2023-08-01Rule 506(b)Equity; OptionToAcquire2023-07-25$30,000,000$30,000,000$07
2011-07-11Rule 506Equity; OptionToAcquire; SecurityToBeAcquired2011-07-01$24,000,001$24,000,001$022

Similar stocks

Stock NameCountryMarket CapPE Ratio
Clene Inc. (CLNN)United States$0.054B-1.99
Serina Therapeutics, Inc. (SER)United States$0.054B-2.35
Annovis Bio, Inc. (ANVS)United States$0.056B-1.58
Xilio Therapeutics, Inc. (XLO)United States$0.052B
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
TALPHERA, INC. (TLPH)United States$0.060B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
CalciMedica, Inc. (CALC)United States$0.061B-1.42
Lite Strategy, Inc. (LITS)United States$0.049B